4 clinics shown
Psychiatric services are provided by Aaron Hawkins at an outpatient practice on Airport Road in Auburn. The practice focuses on medication management and psychiatric evaluations for adults. Specific treatment modalities such as TMS, esketamine, or ketamine therapy are not detailed in available information; prospective patients should inquire directly about available services beyond standard psychiatric care.
Auburn University Medical Clinic operates on the Auburn campus at 400 Lem Morrison Drive, providing general medical services to students, faculty, and staff. The facility functions as a primary care center rather than a psychiatric specialty practice. Patients seeking TMS therapy, esketamine, or ketamine treatments for depression would need referrals to psychiatric providers in the Auburn-Opelika area or nearby Montgomery and Birmingham.
The Neurology Center of East Alabama operates a medical clinic on Champions Boulevard in Auburn, providing neurological services to patients in the East Alabama region. The practice is affiliated with East Alabama Health and focuses on neurological conditions rather than psychiatric treatment. Patients seeking TMS therapy, esketamine, or ketamine treatments for depression should confirm availability directly, as these are not standard neurology offerings.
The Hawkins Group operates a psychiatric consultation practice on North Dean Road in Auburn, serving adults and adolescents with mood disorders, anxiety, ADHD, and related conditions. The practice provides diagnostic evaluations, medication management, and psychotherapy in an outpatient setting. Specific procedural treatments such as TMS or esketamine are not listed in available information; patients requiring those interventions should inquire directly about current offerings or referral options.
Spravato is the brand name for esketamine, an FDA-approved nasal spray for treatment-resistant depression and major depressive disorder with suicidal ideation. It's derived from ketamine and works on the brain's glutamate system — a different mechanism than traditional antidepressants like SSRIs.
Treatment is administered only at REMS-certified clinics under direct medical supervision. Patients self-administer the spray under a clinician's guidance, then remain at the clinic for at least two hours of monitoring after each dose. The induction phase typically involves twice-weekly sessions for four weeks, followed by weekly or biweekly maintenance dosing depending on response.
Many patients report meaningful symptom improvement within the first one to two weeks — substantially faster than the 4 to 8 weeks typical of oral antidepressants. Spravato is taken alongside an oral antidepressant, not as a replacement.
The most common side effects are dissociation, dizziness, sedation, and elevated blood pressure during and shortly after dosing. These typically resolve within the two-hour monitoring window. Patients cannot drive on the day of treatment.
Most commercial insurance and Medicare cover Spravato for treatment-resistant depression with prior authorization. Clinics offering Spravato in our directory hold active REMS certification and are staffed to provide the required in-clinic monitoring period.